Abstract
Piperine, an alkaloid derived from natural products, has been demonstrated to exert antitumor activities in vivo and in vitro. However, its anti‑tumor effect has not yet been illustrated in the prostate cancer (PCa) metastatic process. Thus, the present study explored the influence of piperine on PCa and the underlying molecular mechanism. Cell migration was detected via the Transwell chamber model. Total protein was identified by western blot analysis. The data revealed that piperine markedly repressed cell proliferation and migration, and induced apoptosis in PCa DU145. In addition, LY294002, an protein kinase B (Akt) inhibitor, greatly suppressed the expression level of phospho (p)‑Akt, matrix metalloproteinase (MMP)‑9 and p‑mammalian target of rapamycin (mTOR), suggesting that the activation of the Akt/mTOR/MMP‑9 signaling pathway may participate in regulating cell migration in PCa. Furthermore, piperine reduced the expression of p‑Akt, MMP‑9 and p‑mTOR. Together, these data indicated that piperine may serve as a promising novel therapeutic agent to better overcome PCa metastasis.
References
Oct 14, 2000·Methods and Findings in Experimental and Clinical Pharmacology·R Mittal, R L Gupta
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Nov 15, 2008·Expert Opinion on Therapeutic Targets·Ioannis KoutroulisStamatios Theocharis
Jun 4, 2011·International Journal of Oncology·Aditya V ShettyMunirathinam Gnanasekar
Aug 21, 2012·The Journal of Nutritional Biochemistry·Carolyn D DoucetteDavid W Hoskin
Jul 5, 2013·PloS One·Abhilash SamykuttyGnanasekar Munirathinam
Jul 23, 2013·Food Chemistry·Minh Truong DoHye Gwang Jeong
Aug 14, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Dong-yun OuyangXian-hui He
Mar 20, 2014·Molecular Cancer·Nagarathinam SelvarajPeter C Hollenhorst
May 9, 2014·PloS One·Neel M FofariaSanjay K Srivastava
May 14, 2014·Molecular Carcinogenesis·Paul B YaffeDavid W Hoskin
Jun 2, 2014·Tuberculosis·Sandeep SharmaInshad Ali Khan
Sep 16, 2014·European Urology·Rute B MarquesWytske M van Weerden
Dec 3, 2014·Cancer Letters·Anna L GreenshieldsDavid W Hoskin
Feb 7, 2015·Toxicology Letters·Carolyn D DoucetteDavid W Hoskin
Jul 4, 2015·Helicobacter·Takeshi ToyodaTetsuya Tsukamoto
Sep 4, 2015·Food & Function·Neeraj K SethiyaS H Mishra
Oct 7, 2015·Oncotarget·Hao PanXian-Hui He
Dec 3, 2015·BioFactors·Vishwa DeepakMagdalena Coetzee
Dec 15, 2015·Oncotarget·Qingmei HeNa Liu
Feb 26, 2016·Oncotarget·Chen LiZhilong Ai
Mar 5, 2016·Oncology Reports·Bo KouHaichen Wang
Apr 23, 2016·Frontiers in Bioscience (Landmark Edition)·Huixing ChenXiaofei Wen
Aug 4, 2016·Apoptosis : an International Journal on Programmed Cell Death·Ozge BerrakNarçin Palavan-Unsal
Dec 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dongli ZhangYanyun Li
Dec 3, 2016·Apoptosis : an International Journal on Programmed Cell Death·Jingwen ZhangKwang Seok Ahn
Jan 12, 2017·Molecular and Cellular Biochemistry·Xiao-Lin AiZhi-Yong Wang
May 17, 2017·World Journal of Urology·Matthew R Cooperberg, June M Chan
Nov 5, 2017·Oncotarget·Hong PanKathleen Kelly
Nov 5, 2017·Oncotarget·Zhiqiang ChenJian Yang
Nov 5, 2017·Cold Spring Harbor Perspectives in Medicine·Alexander DiasRos Eeles